PROGRAM OVERVIEW
This two-day international symposium presented exciting advances in the field of hyperinsulinism, including recent genetic breakthroughs and therapeutic innovations. It also featured a mini-symposium exploring the controversies surrounding neonatal hypoglycemia. The symposium was intended to enhance the management skills and practice of endocrinologists, metabolism specialists, neonatologists, surgeons, pathologists, radiologists, geneticists and nurses as well as basic scientists interested in islet cell biology. The symposium faculty, leaders in the field of hyperinsulinism and hypoglycemia, presented 25 plenary lectures on all aspects of these disorders.
